Supercharged natural killer cells may hold promise for cancer
A type of 'supercharged' immune cell could be mass-produced to help fight cancer.
Oct 9, 2018
0
166
A type of 'supercharged' immune cell could be mass-produced to help fight cancer.
Oct 9, 2018
0
166
A single leukemia cell, unknowingly engineered with the leukemia-targeting chimeric antigen receptor (CAR) lentivirus and infused back into a patient, was able to reproduce and cause a deadly recurrence of B-cell acute lymphoblastic ...
Oct 1, 2018
0
20
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling ...
Aug 21, 2018
0
68
To fight viral infections, your immune system calls on CD8 T cells to kill the infected cells. The CD8 T cells can also be used in immunotherapy approaches to kill cancer cells, including the CAR T cell therapy currently ...
Aug 20, 2018
0
325
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...
Aug 15, 2018
0
175
The doctors who have spent years studying the case call it "a series of fortunate events." What began as a remarkable response to chimeric antigen receptor (CAR) T cell therapy is now providing evidence about the human genome ...
May 30, 2018
0
114
A lot can happen at 160 degrees Fahrenheit: Eggs fry, salmonella bacteria dies, and human skin will suffer third-degree burns. If a car is parked in the sun on a hot summer day, its dashboard can hit 160 degrees in about ...
May 24, 2018
2
279
When a man throws money around on flashy cars, people intuitively interpret this behavior as a sign that he is more interested in short-term sexual relationships than in romantic commitment. This is according to Daniel Kruger ...
May 7, 2018
3
1640
Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed ...
Apr 30, 2018
0
54
New research could help to safely adapt a new immunotherapy—currently only effective in blood cancers—for the treatment of solid cancers, such as notoriously hard-to-treat brain tumours.
Feb 12, 2018
0
62